We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Williams Companies
WMB
$87.7B
| $7.59M | 0.05% |
+285,801
| New | +$7.32M |
|
|
MIC
352
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $7.55M | 0.05% |
197,343
+7,985
| +4% | +$281K |
|
353
HF Sinclair
DINO
$16.4B
| $7.54M | 0.05% |
+229,144
| New | +$7.97M |
|
354
Zillow
ZG
$7.44B
| $7.53M | 0.05% |
61,437
-137,695
| -69% | -$17M |
|
355
Perdoceo Education
PRDO
$1.99B
| $7.43M | 0.05% |
605,868
-118,736
| -16% | -$1.45M |
|
356
Accuray
ARAY
$27.2M
| $7.4M | 0.05% |
1,637,076
+45,076
| +3% | +$211K |
|
|
HRC
357
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.4M | 0.05% |
+65,111
| New | +$7.29M |
|
358
Q32 Bio
QTTB
$450M
| $7.37M | 0.05% |
56,291
+22,726
| +68% | +$2.84M |
|
|
FLXN
359
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $7.36M | 0.05% |
894,614
+120,552
| +16% | +$1.03M |
|
|
EGRX
360
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.36M | 0.05% |
171,840
+13,835
| +9% | +$571K |
|
361
AutoNation
AN
$7.11B
| $7.35M | 0.05% |
77,483
+62,418
| +414% | +$6.12M |
|
|
AEL
362
DELISTED
American Equity Investment Life Holding Company
AEL
| $7.34M | 0.05% |
227,124
-134,588
| -37% | -$4.25M |
|
363
Boston Beer
SAM
$1.89B
| $7.34M | 0.05% |
7,187
-2,068
| -22% | -$2.32M |
|
|
PAE
364
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $7.33M | 0.05% |
823,213
+333,759
| +68% | +$2.87M |
|
365
Sarepta Therapeutics
SRPT
$1.72B
| $7.23M | 0.05% |
92,950
+3,953
| +4% | +$300K |
|
|
CADE
366
DELISTED
Cadence Bancorporation
CADE
| $7.22M | 0.05% |
345,622
-1,008,030
| -74% | -$22.1M |
|
367
StoneX
SNEX
$8.7B
| $7.18M | 0.05% |
598,889
+38,060
| +7% | +$492K |
|
368
Orthofix Medical
OFIX
$475M
| $7.16M | 0.05% |
178,519
+19,260
| +12% | +$814K |
|
369
United Natural Foods
UNFI
$2.96B
| $7.14M | 0.05% |
+193,065
| New | +$7.02M |
|
|
BNFT
370
DELISTED
Benefitfocus, Inc.
BNFT
| $7.05M | 0.05% |
500,346
+51,887
| +12% | +$732K |
|
371
Clearwater Paper
CLW
$280M
| $6.99M | 0.05% |
241,228
+28,467
| +13% | +$889K |
|
372
Regenxbio
RGNX
$627M
| $6.97M | 0.05% |
179,521
-11,943
| -6% | -$427K |
|
|
TPC
373
Tutor Perini Cor
TPC
$4.42B
| $6.94M | 0.05% |
501,407
+47,325
| +10% | +$755K |
|
374
Four Corners Property Trust
FCPT
$2.86B
| $6.94M | 0.05% |
251,271
-123,704
| -33% | -$3.5M |
|
|
SMAR
375
DELISTED
Smartsheet Inc.
SMAR
| $6.84M | 0.05% |
94,555
-67,365
| -42% | -$4.2M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.